Articles by Michael H. Davidson (27)

Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study

Christie M. Ballantyne, Michael H. Davidson, James M. McKenney, Laurence H. Keller, Daiva R. Bajorunas and Richard H. Karas

Journal of Clinical Lipidology 2 ( 2 ): 79 - 90 , 2008

Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses

Nicola Abate, Alberico L. Catapano, Christie M. Ballantyne, Michael H. Davidson, Adam Polis, Steven S. Smugar and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 2 ): 91 - 105 , 2008

Initial Results of a Home Patient Screening Kit for Diabetes and Dyslipidemia

William B. Borden and Michael H. Davidson

Journal of Clinical Lipidology 2 ( 3 ): 202 - 203 , 2008

ABT-335 in Combination with Rosuvastatin Improves Multiple Lipid Ratios in Patients with Mixed Dyslipidemia

Michael H. Davidson, Dawn M. Carlson, Robert M. Guthrie, Maureen T. Kelly, Aditya Lele, Carolyn M. Setze and Darryl J. Sleep

Journal of Clinical Lipidology 2 ( 3 ): 211 - 212 , 2008

Long-Term Use of Colesevelam HCl Improves LDL-C and HDL-C Concentrations in Subjects with Primary Hypercholesterolemia

Michael H. Davidson, Stacey L. Abby, Joanne M. Donovan and Michael R. Jones

Journal of Clinical Lipidology 2 ( 3 ): 212 - 213 , 2008

Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination with Rosuvastatin in Patients with Mixed Dyslipidemia: A Phase 3 Study

Peter H. Jones, Susan M. Buttler, Michael H. Davidson, Moti L. Kashyap, Maureen T. Kelly, Carolyn M. Setze, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 2 ( 3 ): 218 - 219 , 2008

Effects of Niacin Extended-Release/Simvastatin Versus Simvastatin Monotherapy on Plasma Lipids in Patients with or without High Baseline Triglycerides

Richard H. Karas, Daiva R. Bajorunas, Christie M. Ballantyne, Michael H. Davidson, Laurence H. Keller, James McKenney, Robert J. Padley and Roopal B. Thakkar

Journal of Clinical Lipidology 2 ( 3 ): 220 - 221 , 2008

The Combination of Niacin Extended-Release with Simvastatin Improves Lipid Levels in Treatment-Naive Patients

Richard H. Karas, Daiva R. Bajorunas, Michael H. Davidson, Moti Kashyap, Laurence H. Keller, Robert H. Knopp, Robert J. Padley and Roopal B. Thakkar

Journal of Clinical Lipidology 2 ( 3 ): 221 - 222 , 2008

Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein

Michael H. Davidson, Nicola Abate, Christie M. Ballantyne, Alberico L. Catapano, Xia Xu, Jianxin Lin, Elizabeth Rosenberg and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 6 ): 436 - 446 , 2008

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases

Eileen E. Ming, Michael H. Davidson, Sanjay K. Gandhi, Marcelo Marotti, Carolyn G. Miles, Xiongkan Ke and James M. McKenney

Journal of Clinical Lipidology 2 ( 6 ): 453 - 463 , 2008

Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies

Peter H. Jones, Michael H. Davidson, Anne C. Goldberg, Carl J. Pepine, Maureen T. Kelly, Susan M. Buttler, Carolyn M. Setze, Aditya Lele, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 3 ( 2 ): 125 - 137 , 2009

Medical management of patients before the incidence of a cardiovascular event

Michael H. Davidson, Kathleen M. Fox, Sanjay K. Gandhi, Robert L. Ohsfeldt and James M. McKenney

Journal of Clinical Lipidology 3 ( 5 ): 315 - 321 , 2009

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

Michael H. Davidson, Kevin C. Maki, Harold Bays, Roderick Carter and Christie M. Ballantyne

Journal of Clinical Lipidology 3 ( 5 ): 332 - 340 , 2009

Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence

Michael H. Davidson

Journal of Clinical Lipidology 4 ( 1 ): 72 - 73 , 2010

High-density lipoproteins: Marker of cardiovascular risk and therapeutic target

Peter P. Toth and Michael H. Davidson

Journal of Clinical Lipidology 4 ( 5 ): 359 - 364 , 2010

Update on CETP inhibition

Michael H. Davidson

Journal of Clinical Lipidology 4 ( 5 ): 394 - 398 , 2010

A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia

Michael H. Davidson

Journal of Clinical Lipidology 5 ( 2 ): 76 - 81 , 2011

Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease

Kevin C. Maki, Michael H. Davidson, Mary R. Dicklin, Marjorie Bell, MarySue Witchger and Steven B. Feinstein

Journal of Clinical Lipidology 5 ( 3 ): 141 - 151 , 2011

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Michael H. Davidson, Christie M. Ballantyne, Terry A. Jacobson, Vera A. Bittner, Lynne T. Braun, Alan S. Brown, W. Virgil Brown, William C. Cromwell, Ronald B. Goldberg, James M. McKenney, Alan T. Remaley, Allan D. Sniderman, Peter P. Toth, Sotirios Tsimikas, Paul E. Ziajka, Kevin C. Maki and Mary R. Dicklin

Journal of Clinical Lipidology 5 ( 5 ): 338 - 367 , 2011

Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥2 mg/L)

Christie M. Ballantyne, Michael H. Davidson, Carolyn M. Setze and Maureen T. Kelly

Journal of Clinical Lipidology 5 ( 5 ): 401 - 407 , 2011

Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction

Peter P. Toth, Christie M. Ballantyne, Michael H. Davidson, Joanne E. Tomassini, Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, X. Henry Hu and Kaan Tunceli

Journal of Clinical Lipidology 6 ( 2 ): 180 - 191 , 2012

Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: A pooled analysis of controlled studies

Eli M. Roth, Robert S. Rosenson, Peter H. Jones, Michael H. Davidson, Maureen T. Kelly, Carolyn M. Setze, Aditya Lele and Kamlesh Thakker

Journal of Clinical Lipidology 6 ( 6 ): 534 - 544 , 2012

A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study

Michael H. Davidson, Judith Johnson, Michael W. Rooney, Michael L. Kyle and Douglas F. Kling

Journal of Clinical Lipidology 6 ( 6 ): 573 - 584 , 2012

Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting

Mark J. Cziraky, Vincent J. Willey, James M. McKenney, Siddhesh A. Kamat, Maxine D. Fisher, John R. Guyton, Terry A. Jacobson and Michael H. Davidson

Journal of Clinical Lipidology 7 ( 2 ): 102 - 108 , 2013

Effect of colesevelam and niacin on low-density lipoprotein cholesterol and glycemic control in subjects with dyslipidemia and impaired fasting glucose

Michael H. Davidson, Michael Rooney, Elisabeth Pollock, Joan Drucker and Young Choy

Journal of Clinical Lipidology 7 ( 5 ): 423 - 432 , 2013

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report

Scott M. Grundyemail, Hidenori Arai, Philip Barter, Thomas P. Bersot, D. John Betteridge, Rafael Carmena, Ada Cuevas, Michael H. Davidson, Jacques Genest, Y. Antero Kesaniemi, Shaukat Sadikot, Raul D. Santos, Andrey V. Susekov, Rody G. Sy, S. LaleTokgozoglu, Gerald F. Watts and Dong Zhao

Journal of Clinical Lipidology 8 ( 1 ): 29 - 60 , 2014

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

John J.P. Kastelein, Kevin C. Maki, Andrey Susekov, Marat Ezhov, Borge G. Nordestgaard, Ben N. Machielse, Douglas Kling and Michael H. Davidson

Journal of Clinical Lipidology 8 ( 1 ): 94 - 106 , 2014

Do you have a suggestion for journals

Suggest Journal